CACCIATORE, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 4.816
EU - Europa 4.548
AS - Asia 3.102
SA - Sud America 266
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 12.759
Nazione #
US - Stati Uniti d'America 4.744
SG - Singapore 1.252
IT - Italia 1.200
CN - Cina 1.039
IE - Irlanda 677
UA - Ucraina 543
SE - Svezia 492
GB - Regno Unito 420
TR - Turchia 402
DE - Germania 378
FR - Francia 376
BR - Brasile 238
IN - India 211
FI - Finlandia 150
RU - Federazione Russa 105
VN - Vietnam 55
HK - Hong Kong 47
CA - Canada 44
AT - Austria 38
BE - Belgio 34
PL - Polonia 25
CZ - Repubblica Ceca 22
NL - Olanda 22
BD - Bangladesh 21
MX - Messico 16
GR - Grecia 15
IR - Iran 13
JP - Giappone 12
ES - Italia 11
IQ - Iraq 11
LT - Lituania 11
AR - Argentina 9
CH - Svizzera 9
PK - Pakistan 9
EU - Europa 7
EC - Ecuador 6
IL - Israele 6
MA - Marocco 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
DK - Danimarca 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
UY - Uruguay 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
ID - Indonesia 2
JO - Giordania 2
KR - Corea 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SM - San Marino 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VE - Venezuela 1
Totale 12.759
Città #
Singapore 934
Chandler 880
Dublin 669
Jacksonville 647
Southend 300
Princeton 272
Chieti 250
Beijing 223
Izmir 218
Nanjing 192
Ashburn 191
The Dalles 164
Dearborn 151
Ann Arbor 147
Santa Clara 143
Munich 137
Wilmington 122
New York 118
Pescara 109
Cambridge 98
Altamura 94
Tongling 88
Boardman 69
Los Angeles 64
Nanchang 64
Rome 55
Shenyang 50
Dong Ket 43
Hong Kong 42
Hefei 41
Kunming 39
Woodbridge 39
Tianjin 38
Helsinki 37
Hebei 32
Brussels 31
Jinan 28
Frankfurt am Main 27
Falls Church 26
Seattle 26
São Paulo 25
Vienna 24
Milan 23
Washington 23
Nuremberg 22
Jiaxing 21
Norwalk 21
Zhengzhou 20
Brno 18
Grevenbroich 18
Kocaeli 17
Changsha 16
Chicago 16
Augusta 15
Boston 15
Toronto 15
Ancona 14
Guangzhou 14
London 14
Turku 14
Leawood 13
Ningbo 13
Silvi 13
Teramo 13
Hangzhou 12
San Francisco 12
Bologna 11
Brasília 11
Houston 11
Moscow 11
Romola 11
Roubaix 11
Changchun 10
Kraków 10
Lanzhou 10
San Mateo 10
Tokyo 10
Brooklyn 9
Ottawa 9
Warsaw 9
Bexley 8
Dallas 8
L’Aquila 8
Naples 8
Perugia 8
Pune 8
San Jose 8
Santa Maria Imbaro 8
Shanghai 8
Amsterdam 7
Ardabil 7
Catania 7
Haikou 7
Lanciano 7
Mexico City 7
Stockholm 7
Taizhou 7
Villaverla 7
Atlanta 6
Auburn Hills 6
Totale 7.629
Nome #
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 334
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 158
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 155
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 143
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 139
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 138
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 137
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 134
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 134
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 131
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 130
Synthesis of a novel TRH-related sulphonamido peptide 129
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 128
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 127
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 127
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 125
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 122
NSAID Coniugates for the treatment of Alzheimer's Disease 122
2,5-Diketopiperazines as neuroprotective agents 120
Carvacrol prodrugs as novel antimicrobial agents 119
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 118
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 118
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 118
Effect of MRJF4 on C6 glioma cells proliferation and migration 117
Advances in prodrug design for Parkinson's disease 117
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 115
Carvacrol codrugs: A new approach in the antimicrobial plan 115
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 113
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 112
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 111
Carvacrol and its derivatives as antibacterial agents 111
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 111
Synthesis and antioxidant properties of novel memantine derivatives 111
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 110
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 110
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 109
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 109
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 109
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 109
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 106
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 106
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 105
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 105
GPE and GPE analogues as promising neuroprotective agents 102
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 101
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 101
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 100
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 100
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 98
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 98
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 98
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 97
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 97
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 96
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 94
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 94
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 94
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 93
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 93
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 93
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 93
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 93
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 93
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 92
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 92
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 90
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 89
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 89
Synthesis of GPE analogues as potential neuroprotective agents 88
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 87
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 87
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 87
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 87
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 87
Role of Dietary Supplements in the Management of Parkinson's Disease 87
Natural oxyprenylated coumarins are modulators of melanogenesis 87
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 86
Synthesis and biological activity of new inhibitors of pantetheine hydrolase 85
Dimeric L-dopa derivatives as potential prodrugs. 85
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 85
Molecular mechanism undelying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model 84
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 84
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 83
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 83
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 83
Multiple lipid nanoparticles as antimicrobial drug delivery systems 83
Prodrug approach for increasing cellular glutathione levels 82
Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. 82
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 81
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 81
Chimica Farmaceutica 80
Recent tools to overcome antibacterial resistance 80
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 80
Synthesis and biological evaluation of the disulfide form of the glutathione analogue gamma-(L-glutamyl)-L-cysteinyl-L-aspartyl-L-cysteine. 79
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 78
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 78
New L-Dopa codrugs as potential antiparkinson agents 78
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 77
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-kB and Nrf2 signalling 77
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 76
Totale 10.444
Categoria #
all - tutte 55.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021757 0 4 131 24 55 146 19 25 90 108 72 83
2021/2022749 32 22 10 74 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.295 97 66 72 47 63 409 273 70 20 22 25 131
2024/20253.166 161 584 519 119 42 188 111 177 255 156 354 500
2025/2026612 544 68 0 0 0 0 0 0 0 0 0 0
Totale 13.248